Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

Eton Pharmaceuticals (Nasdaq: ETON) said members of its executive leadership will host 1x1 meetings at the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025 in New York, NY.

Rhea-AI Summary

Eton Pharmaceuticals (Nasdaq: ETON) said members of its executive leadership will host 1x1 meetings at the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025 in New York, NY.

Investors or institutional representatives seeking a meeting are instructed to contact their Craig-Hallum institutional sales representative to schedule a 1x1.

Argus Nov 13 session

-3.32% close to close Open Argus

Details

News Market Reaction – ETON

On Nov 13, the first trading day after this news, ETON closed 3.32% below the previous close.

Data tracked by StockTitan Argus for the Nov 13 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host 1x1 meetings at the 16th Annual Craig-Hallum Alpha Select Conference being held November 18, 2025 in New York, NY.

To schedule a 1x1 meeting with the Company, please contact your Craig-Hallum institutional sales representative.

About Eton Pharmaceuticals
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX^®, ALKINDI SPRINKLE^®, GALZIN^®, PKU GOLIKE^®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has five additional product candidates in late-stage development: ET-600, Amglidia^®, ET-700, ET-800 and ZENEO^® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Eton Pharmaceuticals (ETON) attend the Craig-Hallum Alpha Select Conference?

Eton will participate on November 18, 2025 at the 16th Annual Craig-Hallum Alpha Select Conference in New York.

How can investors schedule a 1x1 meeting with Eton Pharmaceuticals (ETON) at the conference?

To schedule a 1x1, contact your Craig-Hallum institutional sales representative.

Who from Eton Pharmaceuticals (ETON) will be available at the November 18, 2025 conference?

Members of Eton's executive leadership team will host the 1x1 meetings.

Where is the Craig-Hallum Alpha Select Conference being held for Eton Pharmaceuticals (ETON)?

The conference is being held in New York, NY on November 18, 2025.

Is there public webcast or presentation from Eton Pharmaceuticals (ETON) at the Craig-Hallum conference?

The announcement notes 1x1 meetings with executives; it does not mention a public webcast or general presentation.

Can retail investors request a meeting with Eton Pharmaceuticals (ETON) at the November 18, 2025 conference?

Meetings are arranged through Craig-Hallum institutional sales representatives, which typically serve institutional investors.